Mohit Bansal
Stock Analyst at Wells Fargo
Total Price Targets
37
Stocks Covered
16
Sectors
Healthcare
Most Recent
Mar 12, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Mohit Bansal
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | $150.00 | $111.89 | +34.1% | 3 | Mar 12, 2026 |
| GILD | Gilead Sciences, Inc. | $165.00 | $132.04 | +25.0% | 2 | Feb 11, 2026 |
| BMY | Bristol-Myers Squibb Company | $60.00 | $58.22 | +3.1% | 2 | Feb 6, 2026 |
| LLY | Eli Lilly and Company | $1280.00 | $961.67 | +33.1% | 5 | Feb 5, 2026 |
| MIST | Milestone Pharmaceuticals Inc. | $8.00 | $1.86 | +329.0% | 1 | Dec 16, 2025 |
| REGN | Regeneron Pharmaceuticals, Inc. | $700.00 | $703.72 | -0.5% | 4 | Nov 20, 2025 |
| BMRN | BioMarin Pharmaceutical Inc. | $70.00 | $54.20 | +29.2% | 2 | Oct 28, 2025 |
| BIIB | Biogen Inc. | $165.00 | $186.69 | -11.6% | 3 | Feb 12, 2025 |
| IRWD | Ironwood Pharmaceuticals, Inc. | $7.00 | $4.46 | +57.1% | 3 | Jan 31, 2025 |
| VRTX | Vertex Pharmaceuticals Incorporated | $460.00 | $425.06 | +8.2% | 1 | Jan 30, 2025 |
| TVTX | Travere Therapeutics, Inc. | $27.00 | $44.19 | -38.9% | 1 | Oct 21, 2024 |
| AMGN | Amgen Inc. | $335.00 | $328.69 | +1.9% | 4 | Aug 7, 2024 |
| PFE | Pfizer Inc. | $30.00 | $26.38 | +13.7% | 3 | Jul 31, 2024 |
| HALO | Halozyme Therapeutics, Inc. | $58.00 | $64.04 | -9.4% | 1 | Jun 7, 2024 |
| NBIX | Neurocrine Biosciences, Inc. | $170.00 | $131.64 | +29.1% | 1 | Apr 23, 2024 |
| ABBV | AbbVie Inc. | $165.00 | $206.29 | -20.0% | 1 | Dec 8, 2021 |
Recent Activity
- Mar 12, 2026— Set$150.00price target onMRK(Merck & Co., Inc.)
- Feb 11, 2026— Set$165.00price target onGILD(Gilead Sciences, Inc.)
- Feb 6, 2026— Set$60.00price target onBMY(Bristol-Myers Squibb Company)
- Feb 5, 2026— Set$1280.00price target onLLY(Eli Lilly and Company)
- Dec 16, 2025— Set$8.00price target onMIST(Milestone Pharmaceuticals Inc.)
- Nov 20, 2025— Set$700.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Oct 28, 2025— Set$70.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Aug 1, 2025— Set$580.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Feb 12, 2025— Set$165.00price target onBIIB(Biogen Inc.)
- Jan 31, 2025— Set$7.00price target onIRWD(Ironwood Pharmaceuticals, Inc.)
- Jan 30, 2025— Set$460.00price target onVRTX(Vertex Pharmaceuticals Incorporated)
- Oct 23, 2024— Set$1050.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Oct 21, 2024— Set$27.00price target onTVTX(Travere Therapeutics, Inc.)
- Aug 9, 2024— Set$12.00price target onIRWD(Ironwood Pharmaceuticals, Inc.)
- Aug 9, 2024— Set$1000.00price target onLLY(Eli Lilly and Company)
- Aug 7, 2024— Set$335.00price target onAMGN(Amgen Inc.)
- Jul 31, 2024— Set$30.00price target onPFE(Pfizer Inc.)
- Jun 27, 2024— Set$115.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Jun 12, 2024— Set$140.00price target onMRK(Merck & Co., Inc.)
- Jun 7, 2024— Set$58.00price target onHALO(Halozyme Therapeutics, Inc.)
Frequently Asked Questions
Who is Mohit Bansal?
Mohit Bansal is a stock analyst at Wells Fargo covering 16 stocks primarily in Healthcare. They have issued 37 price targets since Dec 8, 2021.
What stocks does Mohit Bansal cover?
Mohit Bansal currently covers 16 stocks, including LLY, REGN, AMGN, MRK, BIIB.
What is Mohit Bansal's latest price target?
Mohit Bansal's most recent price target was $150.00 on MRK (Merck & Co., Inc.), set on Mar 12, 2026.
What is Mohit Bansal's highest price target?
Mohit Bansal's highest issued price target is $1280.00 on LLY, set on Feb 5, 2026.
More Analysts at Wells Fargo
Coverage based on publicly published price targets. Not investment advice.